Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.35 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.35 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.34 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.33 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.32 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7492135 | 0.91 | MRGPRX4 (0.38) | MRGPRX4SLC6A9PTGER1TRPM8HCRTR1 | |
| SCHEMBL7486887 | 0.85 | F2 (0.44) | SLC6A9PTGER1EGFR | |
| SCHEMBL7487818 | 0.84 | MRGPRX4 (0.34) | MRGPRX4SLC6A9PTGER1TRPM8ADAM17 | |
| SCHEMBL7497007 | 0.84 | PTGER1 (0.39) | MRGPRX4SLC6A9PTGER1HCRTR1HCRTR2 | |
| SCHEMBL7490133 | 0.84 | MRGPRX4 (0.35) | MRGPRX4SLC6A9PTGER1ADAM17MAPT | |
| SCHEMBL7488101 | 0.83 | MAPT (0.36) | MRGPRX4SLC6A9PTGER1TRPM8MAPT | |
| SCHEMBL7489747 | 0.82 | TRPM8 (0.38) | MRGPRX4SLC6A9PTGER1TRPM8MAPT | |
| SCHEMBL7485918 | 0.82 | SLC6A9 (0.39) | MRGPRX4SLC6A9PTGER1MAPTEGFR | |
| SCHEMBL7485494 | 0.81 | TRPM8 (0.34) | MRGPRX4SLC6A9PTGER1TRPM8MAPT | |
| SCHEMBL7495685 | 0.81 | MRGPRX4 (0.35) | MRGPRX4SLC6A9PTGER1TRPM8ADAM17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0929547-B1 | BENZAMIDINE DERIVATIVES SUBSTITUTED BY CYCLIC AMINO ACID OR CYCL IC HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS | SCHERING AG (DE) | 2002-11-27 | — | — | EP | disclosed |
| US-6265404-B1 | FACTOR X INHIBITOR | BERLEX LABORATORIES, INC. | 2001-07-24 | — | — | US | disclosed |
| US-6232325-B1 | THROMBOSIS THERAPY | BERLEX LABORATORIES, INC. | 2001-05-15 | — | — | US | disclosed |
| US-6177473-B1 | FACTOR X INHIBITOR | BERLEX LABORATORIES, INC. | 2001-01-23 | — | — | US | disclosed |
| US-6008234-A | TREATING A HUMAN HAVING A DISEASE-STATE CHARACTERIZED BY THROMBOTIC ACTIVITY, INHIBITING HUMAN BLOOD COAGULATION FACTOR XA | BERLEX LABORATORIES, INC. (US) | 1999-12-28 | — | — | US | disclosed |